EVH (Evolent Health) Price-to-Operating-Cash-Flow : 66.11 (As of Jun. 26, 2025)

View and export this data going back to 2015. Start your Free Trial

What is Evolent Health Price-to-Operating-Cash-Flow?

As of today (2025-06-26), Evolent Health's share price is $10.71. Evolent Health's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2025 was $0.16. Hence, Evolent Health's Price-to-Operating-Cash-Flow Ratio for today is 66.11.

The historical rank and industry rank for Evolent Health's Price-to-Operating-Cash-Flow or its related term are showing as below:

EVH' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 9.43 Med: 60.97 Max: 211.11
Current: 66.07

During the past 12 years, Evolent Health's highest Price-to-Operating-Cash-Flow Ratio was 211.11. The lowest was 9.43. And the median was 60.97.

EVH's Price-to-Operating-Cash-Flow is ranked worse than
91.15% of 497 companies
in the Healthcare Providers & Services industry
Industry Median: 11.68 vs EVH: 66.07

Evolent Health's Cash Flow from Operations per share for the three months ended in Mar. 2025 was $0.04. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2025 was $0.16.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Evolent Health was -88.20% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -28.60% per year.

During the past 12 years, Evolent Health's highest 3-Year average Operating Cash Flow per Share Growth Rate was 38.10% per year. The lowest was -30.30% per year. And the median was 12.85% per year.

Evolent Health Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Evolent Health's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Evolent Health Price-to-Operating-Cash-Flow Chart

Evolent Health Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

61.49

25.76

68.60

Evolent Health Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															23.85	12.29	23.97	68.60	58.46

Competitive Comparison of Evolent Health's Price-to-Operating-Cash-Flow

For the Health Information Services subindustry, Evolent Health's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Evolent Health's Price-to-Operating-Cash-Flow Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Evolent Health's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Evolent Health's Price-to-Operating-Cash-Flow falls into.

Save Embed

;

Save Embed

;

Evolent Health Price-to-Operating-Cash-Flow Calculation

Evolent Health's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	10.71	/	0.162
	=	66.11

Evolent Health's Share Price of today is $10.71.
Evolent Health's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.16.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Evolent Health Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Evolent Health's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Evolent Health Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Evolent Health Inc (NYSE:EVH) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

9EH:Germany

Address

1812 N. Moore Street, Suite 1705, Arlington, VA, USA, 22209

Website

https://www.evolenthealth.com

Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The primary solutions provided by the company include specialty care management services, total cost of care management, and administrative services.

Executives

Richard M Jelinek	director	40 W 47TH STREET, FLOOR 33, NEW YORK NY 10035
Kim Keck	director	30 W. MONROE STREET, SUITE 1200, CHICAGO IL 60603
Peter J Grua	director	C/O HLM VENTURE PARTNERS, 800 SOUTH STREET, SUITE 620, WALTHAM MA 02453
Daniel Joseph Mccarthy	officer: PRESIDENT	800 N GLEBE ROAD, SUITE 500, ARLINGTON VA 22203
Craig A. Barbarosh	director	3525 PIEDMONT RD., NE, BUILDING 6, SUITE 700, ATLANTA GA 30305
Seth Blackley	officer: President	800 N. GLEBE ROAD, SUITE 500, ARLINGTON VA 22203
Diane Holder	director	800 GLEBE ROAD, SUITE 500, ARLINGTON VA 22203
John Paul Johnson	officer: Chief Financial Officer	800 NORTH GLEBE ROAD, SUITE 500, ARLINGTON VA 22203
Emily Ann Rafferty	officer: Chief Operating Officer	800 N. GLEBE ROAD, SUITE 500, ARLINGTON VA 22203
Jonathan Weinberg	officer: General Counsel	800 N. GLEBE ROAD, SUITE 500, ARLINGTON VA 22203
Toyin Ajayi	director	800 NORTH GLEBE ROAD, SUITE 500, ARLINGTON VA 22203
Cheryl Scott	director	800 N. GLEBE ROAD, SUITE 500, ARLINGTON VA 22203
Mary Bridget Duffy	director	C/O VOCERA COMMUNICATIONS, INC., 525 RACE STREET, SAN JOSE CA 95126
Frank J Williams	director, officer: Chief Executive Officer	800 NORTH GLEBE ROAD, SUITE 500, ARLINGTON VA 22203
Steve Tutewohl	officer: Chief Operating Officer	800 NORTH GLEBE ROAD, SUITE 500, ARLINGTON VA 22203